Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-23-027588

Chief Executive Officer gave up 7,172 shares (to pay taxes)

  • Chief Executive Officer acquired 24,474 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Robinson Chandler Chief Executive Officer 2023-09-30 Option exercise +24,474 135,598.8 D
Robinson Chandler Chief Executive Officer 2023-09-30 Shares withheld for taxes −7,172 $0.62 $4,446 128,426.8 D
Derivatives
Robinson Chandler Chief Executive Officer 2023-09-30 Option exercise · Restricted Stock Units −24,474 253,483 D
Loading xslF345X05/rdgdoc.xml…